Who
Frederick M. Lowery
Director
Company insider
Files Form 4 as: Director, DuPont de Nemours; CEO, Henry Schein; Executive Vice President, Thermo Fisher Scientific.
In numbers
- Trades disclosed
- 80
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $17.9M
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 3 Jun 2019
- Last trade
- 28 Aug 2026
- Last filed
- 1 Sep 2026
Companies traded
Activity over time
1 Feb 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 Aug 2026filed 1 Sep 2026 | DD DuPont de NemoursChemicals | SEC FORM 4 Code A | $39K282.888 at $136.98 | filing |
| 28 Aug 2026filed 1 Sep 2026 | DD DuPont de NemoursChemicals | SEC FORM 4 Code A | $39K282.89 at $136.98 | filing |
| 29 May 2026filed 2 Jun 2026 | DD DuPont de NemoursChemicals | SEC FORM 4 Code A | $39K800.289 at $48.42 | filing |
| 29 May 2026filed 2 Jun 2026 | DD DuPont de NemoursChemicals | SEC FORM 4 Code A | $39K800.29 at $48.42 | filing |
| 21 May 2026filed 28 May 2026 | DD DuPont de NemoursChemicals | SEC FORM 4 Code A | —4,030 at $0.00 | filing |
| 21 May 2026filed 28 May 2026 | DD DuPont de NemoursChemicals | SEC FORM 4 Code A | —4,030 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | HSIC Henry ScheinHealth Care Distribution | SEC FORM 4 Code A | —64,433 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | HSIC Henry Scheinoption or derivative · Health Care Distribution | SEC FORM 4 Code A | —177,116 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | HSIC Henry Scheinoption or derivative · Health Care Distribution | SEC FORM 4 Code A | —177,116 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | HSIC Henry ScheinHealth Care Distribution | SEC FORM 4 Code A | —64,433 at $0.00 | filing |
| 2 Mar 2026filed 3 Mar 2026 | HSIC Henry ScheinHealth Care Distribution | SEC FORM 4 Code A | —30,723 at $0.00 | filing |
| 2 Mar 2026filed 3 Mar 2026 | HSIC Henry ScheinHealth Care Distribution | SEC FORM 4 Code A | —30,723 at $0.00 | filing |
| 28 Feb 2026filed 2 Mar 2026 | TMO Thermo Fisher ScientificLife-science tools | SEC FORM 4 Code F | $58K111.281 at $521.11 | filing |
| 28 Feb 2026filed 2 Mar 2026 | TMO Thermo Fisher ScientificLife-science tools | SEC FORM 4 Code F | $272K521.696 at $521.11 | filing |
| 28 Feb 2026filed 2 Mar 2026 | TMO Thermo Fisher ScientificLife-science tools | SEC FORM 4 Code F | $138K263.991 at $521.11 | filing |
| 28 Feb 2026filed 2 Mar 2026 | TMO Thermo Fisher ScientificLife-science tools | SEC FORM 4 Code F | $58K111.28 at $521.11 | filing |
| 28 Feb 2026filed 2 Mar 2026 | TMO Thermo Fisher ScientificLife-science tools | SEC FORM 4 Code F | $272K521.7 at $521.11 | filing |
| 28 Feb 2026filed 2 Mar 2026 | TMO Thermo Fisher ScientificLife-science tools | SEC FORM 4 Code F | $138K263.99 at $521.11 | filing |
| 27 Feb 2026filed 3 Mar 2026 | DD DuPont de NemoursChemicals | SEC FORM 4 Code A | $39K774.38 at $50.04 | filing |
| 27 Feb 2026filed 3 Mar 2026 | DD DuPont de NemoursChemicals | SEC FORM 4 Code A | $39K774.38 at $50.04 | filing |
News
Thermo Fisher Scientific Outperforms on Strong Results and Life Sciences RecoveryTMO · insidermonkey.com · 16 Oct 2026Thermo Fisher Scientific Inc. $TMO Shares Acquired by Artemis Investment Management LLPTMO · dailypolitical.com · 8 Oct 2026
0 headlines in the last 90 days name Frederick M. Lowery; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.